Siemens showcases 3T, 1.5T scanners
Siemens Healthcare is focusing on its 3T Verio and 1.5T Essenza at the ISMRM meeting. Both were unveiled last year at the RSNA meeting.
Siemens Healthcare is focusing on its 3T Verio and 1.5T Essenza at the ISMRM meeting. Both were unveiled last year at the RSNA meeting.
Twenty of the wide-bore 3T scanners are operating, even though Verio began shipping only last month. Essenza sites are also running in Europe, Asia, and the U.S.
Verio's 70-cm bore offers more patient-friendly positioning, according to the company, while its off-center scanning with dedicated coils shortens the workflow and improves data acquisition. Its ultracompact magnet, measuring 173 cm long, has the footprint of a 1.5T MRI system. All told, it weighs a relatively light six tons.
The scanner comes equipped with the company's own breed of coil technology, based on Tim (total imaging matrix) technology, which supports up to 102 integrated matrix coil elements and up to 32 radiofrequency channels.
Priced under a million dollars, Essenza's appeal is as an inexpensive 1.5T workhorse. The company is targeting budget-strapped first-time buyers who otherwise might purchase refurbished or low-end technology, as well as institutions that already have MR but want to increase capacity and decrease waiting times for patients.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
New bpMRI Study Suggests AI Offers Comparable Results to Radiologists for PCa Detection
April 15th 2025Demonstrating no significant difference with radiologist detection of clinically significant prostate cancer (csPCa), a biparametric MRI-based AI model provided an 88.4 percent sensitivity rate in a recent study.
Could Ultrafast MRI Enhance Detection of Malignant Foci for Breast Cancer?
April 10th 2025In a new study involving over 120 women, nearly two-thirds of whom had a family history of breast cancer, ultrafast MRI findings revealed a 5 percent increase in malignancy risk for each second increase in the difference between lesion and background parenchymal enhancement (BPE) time to enhancement (TTE).
